Mirabegron
178-CL-204
Phase 3 small_molecule terminated
Quick answer
Mirabegron for Overactive Bladder (OAB) is a Phase 3 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Overactive Bladder (OAB)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated